The_DT Product_NN of_IN the_DT Survival_NP of_IN Motor_NP Neuron_NP (_( SMN_NP )_) Gene_NP is_VBZ a_DT Human_NP Telomerase-associated_NP Protein_NP Telomerase_NP is_VBZ a_DT ribonucleoprotein_NN (_( RNP_NP )_) complex_NN that_WDT is_VBZ minimally_RB composed_VBN of_IN a_DT protein_NN catalytic_JJ subunit_NN ,_, the_DT telomerase_NN reverse_NN transcriptase_NN (_( TERT_NP )_) ,_, and_CC an_DT RNA_NP component_NN ,_, the_DT telomerase_NN RNA_NP ._SENT The_DT survival_NN of_IN motor_NN neuron_NN (_( SMN_NP )_) gene_NN codes_NNS for_IN a_DT protein_NN involved_VBN in_IN the_DT biogenesis_NN of_IN certain_JJ RNPs_NP ._SENT Here_RB ,_, we_PP report_VBP that_IN SMN_NP is_VBZ a_DT telomerase-associated_JJ protein_NN ._SENT Using_VBG in_IN vitro_NN binding_VBG assays_NNS and_CC immunoprecipitation_NN experiments_NNS ,_, we_PP demonstrate_VBP an_DT association_NN between_IN SMN_NP and_CC the_DT telomerase_NN RNP_NN in_IN vitro_NN and_CC in_IN human_JJ cells_NNS ._SENT The_DT specific_JJ immunopurification_NN of_IN SMN_NN from_IN human_JJ 293_CD cells_NNS copurified_JJ telomerase_NN activity_NN ,_, suggesting_VBG that_IN SMN_JJ associates_NNS with_IN a_DT subset_NN of_IN the_DT functional_JJ telomerase_NN holoenzyme_NN ._SENT Our_PP$ results_NNS also_RB indicate_VBP that_IN the_DT human_JJ telomerase_NN RNA_NP and_CC the_DT human_JJ (_( h_NN )_) TERT_NP are_VBP not_RB associated_VBN with_IN Sm_NN proteins_NNS ,_, in_IN contrast_NN to_TO Saccharomyces_NP cerevisiae_NNS telomerase_NN ._SENT Immunofluorescence_NN analysis_NN showed_VBD that_IN hTERT_NP does_VBZ not_RB specifically_RB colocalize_VB with_IN wild-type_NN SMN_NNS in_IN gems_NNS or_CC Cajal_JJ bodies_NNS ._SENT However_RB ,_, a_DT dominant-negative_JJ mutant_NN of_IN SMN_NP (_( SMNDeltaN27_NP )_) previously_RB characterized_VBD to_TO elicit_VB the_DT cellular_JJ reorganization_NN of_IN small_JJ nuclear_JJ RNPs_NP caused_VBD the_DT accumulation_NN of_IN hTERT_NN in_IN specific_JJ SMNDeltaN27-induced_JJ cellular_JJ bodies_NNS ._SENT Furthermore_RB ,_, coexpression_NN of_IN SMNDeltaN27_JJ and_CC hTERT_NN in_IN rabbit_NN reticulocyte_NN lysates_NNS decreased_VBD the_DT efficiency_NN of_IN human_JJ telomerase_NN reconstitution_NN in_IN vitro_NN ._SENT Our_PP$ results_NNS establish_VB SMN_NNS as_IN a_DT novel_JJ telomerase-associated_JJ protein_NN that_WDT is_VBZ likely_JJ to_TO function_VB in_IN human_JJ telomerase_NN biogenesis_NN ._SENT Telomere_NN maintenance_NN in_IN most_JJS eukaryotic_JJ cells_NNS is_VBZ established_VBN by_IN the_DT ribonucleoprotein_NP (_( RNP_NP )_) enzyme_NN telomerase_NN ._SENT The_DT telomerase_NN RNP_NP minimally_RB consists_VBZ of_IN an_DT RNA_NP molecule_NN and_CC a_DT protein_NN catalytic_JJ subunit_NN ,_, the_DT telomerase_NN reverse_NN transcriptase_NN (_( TERT_NP )_) ._SENT Using_VBG an_DT internal_JJ template_NN sequence_NN in_IN the_DT telomerase_JJ RNA_NP subunit_NN ,_, this_DT specialized_JJ reverse_NN transcriptase_NN synthesizes_VBZ simple_JJ guanine-rich_NN sequences_NNS at_IN the_DT 3'-end_JJ of_IN chromosomal_JJ DNA_NN ._SENT The_DT telomeric_JJ DNA_NN repeats_NNS and_CC associated_VBN telomere-binding_NN proteins_NNS protect_VBP chromosomes_NNS from_IN nuclease_NN digestion_NN ,_, end-to-end_NN fusions_NNS ,_, and_CC other_JJ DNA_NN rearrangement_NN events_NNS ._SENT The_DT lengths_NNS and_CC nucleotide_NN sequences_NNS of_IN the_DT telomerase_JJ RNA_NP subunits_NN are_VBP highly_RB divergent_JJ ._SENT Secondary_JJ structure_NN prediction_NN suggests_VBZ the_DT presence_NN of_IN a_DT small_JJ nucleolar_JJ (_( sno_NN )_) RNA_NP H/ACA_NP box_NN motif_NN in_IN the_DT 3'-end_JJ of_IN vertebrate_JJ telomerase_NN RNAs_NP ._SENT Mutations_NNS that_WDT perturb_VBP the_DT folding_NN of_IN the_DT H/ACA_NP box_NN of_IN human_JJ and_CC mouse_NN telomerase_NN RNAs_NP prevent_VBP both_DT their_PP$ cellular_JJ accumulation_NN and_CC their_PP$ ability_NN to_TO properly_RB localize_VB to_TO the_DT nucleolus_NN of_IN microinjected_JJ Xenopus_NP oocytes_NNS ._SENT Notably_RB ,_, the_DT human_JJ telomerase_NN RNA_NP (_( hTR_NN )_) associates_NNS with_IN the_DT H/ACA_NP box_NN snoRNA-binding_NN proteins_NNS dyskerin_NN ,_, hGAR1_NN ,_, NH2P_NP ,_, and_CC NOP10_NP ._SENT The_DT role_NN of_IN these_DT proteins_NNS in_IN vertebrate_JJ telomerase_NN function_NN is_VBZ unclear_JJ ._SENT The_DT X-linked_JJ form_NN of_IN the_DT disease_NN dyskeratosis_NN congenita_NN is_VBZ caused_VBN by_IN mutations_NNS in_IN the_DT gene_NN that_WDT encodes_VBZ the_DT protein_NN dyskerin_NN ._SENT Cells_NNS from_IN individuals_NNS affected_VBN by_IN this_DT disease_NN have_VBP low_JJ levels_NNS of_IN hTR_NN and_CC telomerase_NN activity_NN as_RB well_RB as_IN short_JJ telomeres_NNS ,_, supporting_VBG an_DT important_JJ role_NN for_IN snoRNP_NN proteins_NNS in_IN telomerase_NN biogenesis_NN ._SENT Human_JJ telomerase_NN activity_NN is_VBZ detected_VBN in_IN >85_JJ %_NN of_IN cancers_NNS and_CC transformed_VBN cell_NN lines_NNS ,_, whereas_IN it_PP is_VBZ absent_JJ from_IN most_RBS normal_JJ human_JJ cells_NNS ._SENT Inhibition_NN of_IN human_JJ telomerase_NN from_IN immortal_NN and_CC cancer_NN cell_NN lines_NNS results_NNS in_IN telomere_NN shortening_NN and_CC ,_, in_IN certain_JJ cell_NN types_NNS ,_, cell_NN death_NN or_CC senescence_NN ._SENT Consequently_RB ,_, a_DT better_JJR understanding_NN of_IN the_DT mechanisms_NNS involved_VBN in_IN the_DT assembly_NN and_CC regulation_NN of_IN the_DT human_JJ telomerase_NN RNP_NP will_MD be_VB important_JJ for_IN the_DT rational_JJ design_NN of_IN telomerase_NN inhibitors_NNS ._SENT In_IN Saccharomyces_NP cerevisiae_NNS ,_, the_DT telomerase_NN RNA_NP (_( TLC1_NP )_) associates_NNS with_IN the_DT heptameric_JJ Sm_NN protein_NN complex_NN and_CC acquires_VBZ a_DT 5'-2,2,7-trimethylguanosine_JJ (_( TMG_NP )_) cap_NN structure_NN ;_: both_CC of_IN these_DT events_NNS are_VBP hallmarks_NNS of_IN small_JJ nuclear_JJ (_( sn_NN )_) RNP_NP assembly_NN ._SENT Yet_RB ,_, little_RB is_VBZ known_VBN about_IN the_DT molecular_JJ machinery_NN involved_VBN in_IN the_DT localization_NN and_CC assembly_NN of_IN vertebrate_JJ telomerase_NN ._SENT The_DT product_NN encoded_VBN by_IN the_DT survival_NN of_IN motor_NN neuron_NN (_( SMN_NP )_) gene_NN is_VBZ present_JJ both_CC in_IN the_DT cytoplasm_NN and_CC in_IN the_DT nucleus_NN ,_, where_WRB it_PP localizes_VBZ in_IN different_JJ nuclear_JJ structures_NNS :_: gems_NNS ,_, Cajal_JJ bodies_NNS (_( CBs_NP )_) ,_, and_CC the_DT nucleolus_NN ._SENT SMN_NP and_CC a_DT set_NN of_IN associated_JJ proteins_NNS (_( Gemins_NP )_) form_VBP a_DT complex_NN involved_VBN in_IN the_DT biogenesis_NN of_IN at_IN least_JJS four_CD uridine_NN (U)-rich_JJ snRNPs_NNS ,_, U1_NP ,_, U2_NP ,_, U4_NP ,_, and_CC U5_NP ,_, all_DT major_JJ constituents_NNS of_IN the_DT splicing_VBG machinery_NN ._SENT Biochemical_JJ data_NNS demonstrate_VBP that_IN SMN_NP interacts_VBZ directly_RB with_IN the_DT arginine-glycine_NN --_: rich_JJ domain_NN of_IN a_DT subset_NN of_IN Sm_NN proteins_NNS ._SENT The_DT Sm_NP core_NN complex_NN contains_VBZ seven_CD proteins_NNS (_( B/B_NP '_POS ,_, D1_NP --_: D3_NP ,_, E_NP ,_, F_NP ,_, and_CC G_NP )_) predicted_VBD to_TO form_VB a_DT closed_JJ ring_NN structure_NN around_IN a_DT conserved_VBN sequence_NN motif_NN within_IN some_DT of_IN the_DT UsnRNAs_NP ._SENT The_DT precise_JJ function_NN of_IN the_DT SMN_JJ complex_NN is_VBZ not_RB completely_RB characterized_VBN ;_: however_RB ,_, evidence_NN strongly_RB suggests_VBZ that_IN the_DT SMN_JJ complex_NN facilitates_VBZ or_CC stabilizes_VBZ the_DT association_NN of_IN Sm_NN proteins_NNS with_IN U1_NP ,_, U2_NP ,_, U4_NP ,_, and_CC U5_NP snRNAs_NNS and_CC the_DT functional_JJ maturation_NN of_IN UsnRNPs_NP ._SENT Furthermore_RB ,_, using_VBG antibody_NN addition_NN experiments_NNS and_CC a_DT dominant-negative_JJ version_NN of_IN SMN_NN that_WDT lacks_VBZ the_DT first_JJ 27_CD amino_NN acids_NNS (_( SMNDeltaN27_JJ )_) ,_, demonstrated_VBD that_IN SMN_NP might_MD also_RB have_VB a_DT more_RBR direct_JJ role_NN in_IN pre-mRNA_NN splicing_VBG ._SENT As_IN expected_VBN from_IN the_DT wide_JJ range_NN of_IN cellular_JJ pathways_NNS in_IN which_WDT SMN_NP is_VBZ implicated_VBN ,_, disruption_NN of_IN the_DT gene_NN encoding_VBG SMN_NN in_IN different_JJ organisms_NNS is_VBZ lethal_JJ ._SENT The_DT role_NN of_IN the_DT Sm_NP protein_NN complex_NN in_IN S._NP cerevisiae_NNS telomerase_NN biogenesis_NN and_CC the_DT recent_JJ observation_NN that_IN SMN_JJ associates_NNS with_IN snoRNP_NN proteins_NNS ,_, prompted_VBD us_PP to_TO examine_VB whether_IN SMN_NN and/or_CC Sm_NN proteins_NNS are_VBP involved_VBN in_IN human_JJ telomerase_NN function_NN ._SENT We_PP report_VBP that_IN SMN_NP is_VBZ a_DT novel_JJ telomerase-associated_JJ protein_NN ._SENT The_DT human_JJ Sm_NN protein_NN complex_NN does_VBZ not_RB interact_VB with_IN human_JJ (_( h_NN )_) TERT_NP ,_, hTR_NN ,_, or_CC catalytically_RB active_JJ telomerase_NN ,_, suggesting_VBG that_IN the_DT association_NN of_IN SMN_NN with_IN human_JJ telomerase_NN is_VBZ independent_JJ of_IN Sm_NN proteins_NNS ._SENT A_DT previously_RB characterized_VBN dominant-negative_JJ SMN_NN protein_NN (_( SMNDeltaN27_JJ )_) has_VBZ the_DT ability_NN to_TO perturb_VB the_DT normal_JJ subcellular_JJ localization_NN of_IN hTERT_NN and_CC decrease_VB the_DT efficiency_NN of_IN in_IN vitro_NN reconstitution_NN of_IN telomerase_NN in_IN rabbit_NN reticulocyte_NN lysates_NNS (_( RRLs_NP )_) ._SENT On_IN the_DT basis_NN of_IN these_DT and_CC other_JJ recent_JJ results_NNS ,_, we_PP suggest_VBP that_IN SMN_NP is_VBZ involved_VBN in_IN human_JJ telomerase_NN biogenesis_NN as_IN an_DT H/ACA_NP snoRNP_NN ._SENT Experimental_JJ Procedures_NNS |_SYM Construction_NN of_IN Plasmids_NNS ._SENT The_DT cDNAs_NNS encoding_VBG human_JJ SMN_NN and_CC SMNDeltaN27_JJ were_VBD amplified_VBN by_IN RT-PCR_NP using_VBG total_JJ cellular_JJ RNA_NP extracted_VBD from_IN HeLa_NP cells_NNS ._SENT SmB_NP ,_, SmD1_NP ,_, and_CC SmD3_NP cDNAs_NNS were_VBD amplified_VBN by_IN PCR_NP from_IN IMAGE_NP clones_NNS ._SENT Expression_NN of_IN the_DT Myc-tagged_JJ version_NN of_IN these_DT proteins_NNS in_IN cultured_JJ human_JJ cells_NNS or_CC rabbit_NN reticulocyte_NN lysates_NNS was_VBD performed_VBN by_IN cloning_VBG the_DT DNA_NN fragments_VBZ corresponding_JJ to_TO the_DT above-mentioned_JJ cDNAs_NNS into_IN a_DT modified_JJ pcDNA3.1_JJ vector_NN (_( InVitrogen_NP ,_, San_NP Diego_NP ,_, CA_NP )_) containing_VBG the_DT sequence_NN for_IN the_DT Myc-tag_NP epitope_NN ._SENT The_DT expression_NN construct_NN for_IN FLAG-hTERT_NP was_VBD a_DT gift_NN from_IN Dr._NP Lea_NP Harrington_NP (_( Amgen_NP ,_, University_NP of_IN Toronto_NP )_) ._SENT For_IN subcellular_JJ localization_NN experiments_NNS ,_, hTERT_NN cDNA_NN was_VBD subcloned_VBN into_IN the_DT pEGFP-C1_JJ vector_NN (_( Clonetech_NP ,_, Cambridge_NP ,_, UK_NP )_) ._SENT Antibodies_NNS ._SENT The_DT antibodies_NNS used_VBN were_VBD as_RB follows_VBZ :_: mouse_NN monoclonal_NN FLAG_NP antibody_NN (_( Sigma_NP ,_, St._NP Louis_NP ,_, MO_NP )_) ;_: affinity-purified_VBN goat_NN anti-GST_NP serum_NN (_( Amersham_NP Biosciences_NP ,_, Arlington_NP Heights_NP ,_, IL_NP )_) ;_: affinity-purified_VBN rabbit_NN anti-hTERT_NN serum_NN ;_: mouse_NN anti-Sm_NN ;_: affinity-purified_JJ rabbit_NN anti-TEP1_JJ serum_NN ;_: mouse_NN monoclonal_NN anti-SMN_NN (_( clone_NN 8_CD ;_: Transduction_NP Laboratories_NPS ,_, Lexington_NP ,_, KY_NP )_) ;_: mouse_NN monoclonal_NN anti-Myc_NP (_( 9E10_NP ;_: ATCC_NP hybridoma_NP ;_: American_NP Type_NP Culture_NP Collection_NP ,_, Manassas_NP ,_, VA_NP )_) ;_: and_CC mouse_NN monoclonal_NN 2,2,7-TMG-specific_JJ antibody_NN (_( Oncogene_NN Research_NP Products_NP ,_, San_NP Diego_NP ,_, CA_NP )_) ._SENT Cell_NN Culture_NP and_CC Manipulations_NP ._SENT Human_JJ embryonic_JJ kidney_NN cells_NNS (_( 293_CD )_) and_CC HeLa_NP cells_NNS were_VBD grown_VBN in_IN DMEM_NP with_IN 10_CD %_NN fetal_JJ bovine_JJ serum_NN and_CC antibiotics_NNS ._SENT Transient_JJ transfections_NNS of_IN 293_CD and_CC HeLa_NP cells_NNS were_VBD performed_VBN using_VBG Lipofectamine_NP 2000_CD (_( Invitrogen_NP )_) with_IN 1_CD --_: 2_CD mug_NN expression_NN constructs_NNS combined_VBN per_IN 35-mm_JJ dish_NN ._SENT In_IN Vitro_NP Binding_NP Assays_NP ._SENT Reconstitution_NN of_IN active_JJ human_JJ telomerase_NN by_IN coexpression_NN of_IN GST-hTERT_NP and_CC the_DT hTR_NN in_IN yeast_NN was_VBD described_VBN previously_RB ._SENT To_TO investigate_VB SMN_NN and_CC telomerase_NN interaction_NN in_IN vitro_NN ,_, we_PP generated_VBD [_SYM 35S]methionine-labeled_JJ Myc-SMN_NN and_CC luciferase_NN using_VBG an_DT RRL_NP kit_NN as_RB described_VBD per_IN the_DT manufacturer_NN 's_POS instructions_NNS (_( Promega_NP ,_, Madison_NP ,_, WI_NP )_) ._SENT Equal_JJ amounts_NNS of_IN labeled_VBN proteins_NNS were_VBD first_RB precleared_VBN overnight_RB in_IN 1_CD ml_NN of_IN in_IN vitro_NN binding_VBG buffer_NN (_( 50_CD mM_NP Tris_NP ,_, pH_NN 7.5_CD ,_, 200_CD mM_NP NaCl_NP ,_, 2_CD mM_NP EDTA_NP ,_, 0.1_CD %_NN NP-40_NN ,_, and_CC protease_NN inhibitors_NNS )_) ._SENT Immunopurified_JJ human_JJ telomerase_NN RNP_NP was_VBD prepared_VBN by_IN incubating_VBG protein_NN extracts_VBZ from_IN 50_CD ml_NN yeast_NN pellets_NNS with_IN GST-specific_JJ antibody_NN (_( Amersham_NP Biosciences_NP )_) and_CC protein-A_NN --_: Sepharose_NP (_( Sigma_NP )_) in_IN yeast_NN lysis_NN buffer_NN (_( 10_CD mM_NP Tris_NP ,_, pH_NN 7.5_CD ,_, 2_CD mM_NP MgCl2_NP ,_, 5.0_CD mM_NP beta-mercaptoethanol_NN ,_, 20_CD %_NN glycerol_NN ,_, 1_CD %_NN NP-40_NP ,_, 0.25_CD mM_NP sodium_NN deoxycholate_NN ,_, 1.0_CD mM_NP EGTA_NP ,_, and_CC 150_CD mM_NP NaCl_NP ,_, plus_CC protease_NN and_CC RNase_NN inhibitors_NNS )_) ._SENT After_IN a_DT 1-hour_JJ incubation_NN at_IN 4C_JJ ,_, beads_NNS were_VBD washed_VBN 5_CD times_NNS in_IN yeast_NN lysis_NN buffer_NN supplemented_VBN with_IN 500_CD mM_NP NaCl_NP ._SENT The_DT precleared_JJ RRL-synthesized_JJ labeled_VBN proteins_NNS were_VBD then_RB incubated_VBN with_IN the_DT immunopurified_JJ human_JJ telomerase_NN RNP_NN for_IN an_DT additional_JJ 2_CD h_NN at_IN 4C_JJ ._SENT After_IN washing_VBG 5_CD times_NNS with_IN 1_CD ml_NN of_IN in_IN vitro_NN binding_VBG buffer_NN ,_, bound_JJ proteins_NNS were_VBD eluted_VBN by_IN boiling_VBG in_IN SDS-PAGE_NP loading_NN dye_NN and_CC subjected_VBN to_TO electrophoresis_NN ._SENT Immunoprecipitation_NP ,_, Telomerase_NP Activity_NP ,_, and_CC Northern_NP Blotting_NP ._SENT Twenty_CD to_TO 24_CD h_NN after_IN transfection_NN ,_, cells_NNS were_VBD washed_VBN two_CD times_NNS with_IN PBS_NP and_CC resuspended_JJ in_IN 500_CD mul_NN of_IN lysis_NN buffer_NN (_( 20_CD mM_NP HEPES_NP ,_, pH_NN 7.9_CD ,_, 2_CD mM_NP MgCl2_NP ,_, 0.2_CD mM_NP EGTA_NP ,_, 10_CD %_NN glycerol_NN ,_, 1_CD mM_NP DTT_NP ,_, 150_CD mM_NP NaCl_NP ,_, and_CC 1.0_CD %_NN NP-40_NN ,_, plus_CC protease_NN and_CC RNase_NN inhibitors_NNS )_) ._SENT After_IN homogenization_NN by_IN forcing_VBG the_DT cells_NNS five_CD times_NNS through_IN a_DT 25-gauge_JJ needle_NN ,_, the_DT cell_NN suspension_NN was_VBD left_VBN rotating_VBG at_IN 4C_JJ for_IN 30_CD min_NN before_IN the_DT lysate_NN was_VBD cleared_VBN in_IN a_DT microcentrifuge_NN for_IN 15_CD --_: 20_CD min_NN ._SENT For_IN protein_NN coimmunoprecipitation_NN experiments_NNS ,_, cell_NN lysates_NNS were_VBD incubated_VBN with_IN antibodies_NNS for_IN 30_CD min_NN before_IN the_DT addition_NN of_IN protein-A_NN --_: Sepharose_NP for_IN an_DT additional_JJ 1-hour_JJ incubation_NN at_IN 4C_JJ ._SENT After_IN the_DT beads_NNS had_VBD been_VBN washed_VBN four_CD times_NNS with_IN 1_CD ml_NN of_IN lysis_NN buffer_NN ,_, the_DT bound_JJ proteins_NNS were_VBD eluted_VBN and_CC subjected_VBN to_TO SDS-PAGE_NN and_CC immunoblotting_NN ._SENT Five_CD to_TO 10_CD %_NN of_IN immunoprecipitates_NNS were_VBD assayed_VBN for_IN telomerase_NN activity_NN by_IN Telomeric_JJ repeat_NN amplification_NN protocol_NN (_( TRAP_NP )_) as_IN previously_RB described_VBN ._SENT The_DT preparation_NN of_IN HeLa_NP nucleolar-enriched_JJ nuclear_JJ extracts_VBZ was_VBD based_VBN on_IN a_DT previously_RB described_VBN protocol_NN ._SENT To_TO analyze_VB immunoprecipitated_JJ RNAs_NP ,_, HeLa_NP total_JJ cell_NN lysates_NNS were_VBD prepared_VBN from_IN 70_CD --_: 80_CD %_NN confluent_JJ cells_NNS in_IN a_DT 10-cm_NP dish_NN in_IN lysis_NN buffer_NN (_( 20_CD mM_NP HEPES_NP ,_, pH_NN 7.9_CD ,_, 300_CD mM_NP KCl_NP ,_, 10_CD %_NN glycerol_NN ,_, 0.5_CD mM_NP DTT_NP ,_, 1_CD mM_NP EDTA_NP ,_, 2_CD mM_NP MgCl2_NP ,_, and_CC 1_CD %_NN NP-40_NN ,_, plus_CC protease_NN and_CC RNase_NN inhibitors_NNS )_) and_CC subjected_VBN to_TO immunoprecipitation_NN as_IN previously_RB described_VBN ._SENT Probes_NNS used_VBN for_IN Northern_NP blotting_VBG were_VBD DNA_NN oligonucleotides_NNS complementary_JJ to_TO human_JJ U1_NP ,_, U2_NP ,_, and_CC U6_NP snRNAs_NNS and_CC hTR_NN ._SENT Indirect_JJ Immunofluorescence_NN ._SENT HeLa_NP cells_NNS were_VBD cultured_VBN on_IN coverslips_NNS in_IN 6-well_JJ dishes_NNS ._SENT Twenty_CD hours_NNS after_IN transfection_NN ,_, HeLa_NP cells_NNS were_VBD fixed_VBN for_IN 5_CD min_NN in_IN 1.0_CD %_NN paraformaldehyde_NN in_IN PBS_NP ,_, pH_NN 7.5_CD ,_, and_CC then_RB permeabilized_VBN for_IN 5_CD min_NN in_IN 0.5_CD %_NN Triton_NP X-100_NP in_IN PBS_NP ._SENT Myc-tagged_JJ SMN_NN and_CC SMNDeltaN27_JJ proteins_NNS were_VBD labeled_VBN with_IN anti-Myc_NN antibody_NN (_( 9E10_NP ;_: 1:400_LS )_) ._SENT Cells_NNS were_VBD then_RB washed_VBN with_IN 0.1_CD %_NN Triton_NP X-100_NP in_IN PBS_NP ,_, followed_VBN by_IN PBS_NP ,_, and_CC were_VBD then_RB incubated_VBN with_IN secondary_JJ antibody_NN (_( goat_NN anti-mouse_NN Cy3_NP from_IN Chemicon_NP ,_, Temecula_NP ,_, CA_NP )_) for_IN 30_CD min_NN ._SENT Cells_NNS were_VBD rinsed_VBN with_IN 0.1_CD %_NN Triton_NP X-100_NP in_IN PBS_NP or_CC in_IN PBS_NP alone_RB and_CC then_RB mounted_VBN in_IN 1_CD mg/ml_NN para-phenylenediamine_NN in_IN PBS/90_NP %_NN glycerol_NN that_WDT also_RB contained_VBD DAPI_NP at_IN 1_CD mug/ml_NN ._SENT Digital_NP imaging_NN was_VBD performed_VBN with_IN a_DT SPOT_NN cooled_VBD CCD_JJ camera_NN (_( Diagnostic_NP Instruments_NP ,_, Inc._NP ,_, Burroughs_NP ,_, MI_NP )_) mounted_VBD on_IN a_DT Zeiss_NP Axioplan_NP immunofluorescence_NN microscope_NN ._SENT SMN_JJ Associates_NNS with_IN the_DT Human_NP Telomerase_NP RNP_NP In_IN Vitro_NP and_CC In_IN Vivo_NP |_SYM We_PP used_VBD functional_JJ recombinant_JJ human_JJ telomerase_NN expressed_VBN in_IN S._NP cerevisiae_NNS to_TO investigate_VB whether_IN the_DT SMN_JJ protein_NN can_MD form_VB a_DT complex_NN with_IN telomerase_NN in_IN vitro_NN ._SENT First_RB ,_, the_DT GST-hTERT/hTR_NP telomerase_NN complex_NN was_VBD immunopurified_VBN from_IN yeast_NN extracts_VBZ using_VBG an_DT affinity-purified_JJ GST-specific_JJ antibody_NN as_IN described_VBN in_IN Experimental_NP Procedures_NPS ._SENT [_SYM 35S]methionine-labeled_JJ luciferase_NN and_CC SMN_NN proteins_NNS were_VBD generated_VBN in_IN RRLs_NP ._SENT The_DT labeled_VBN proteins_NNS were_VBD incubated_VBN with_IN the_DT recombinant_JJ telomerase_NN RNP_NP previously_RB immobilized_VBD on_IN antibody-coated_JJ Sepharose_NP beads_NNS ._SENT After_IN a_DT 2-h_JJ incubation_NN ,_, the_DT complexes_NNS were_VBD washed_VBN extensively_RB ,_, eluted_VBD ,_, and_CC analyzed_VBD by_IN SDS-PAGE_NP ._SENT Figure_NP A_NP shows_VBZ that_IN SMN_NNS specifically_RB bound_VBN to_TO the_DT GST-hTERT/hTR_NP complex_NN (_( lane_NN 6_CD )_) ,_, whereas_IN SMN_NP did_VBD not_RB bind_VB to_TO GST_JJ alone_RB (_( lane_NN 5_CD )_) ._SENT Treatment_NN of_IN the_DT GST-hTERT/hTR_NP complex_NN with_IN a_DT cocktail_NN of_IN RNases_NNS before_IN addition_NN of_IN [_SYM 35S]-labeled_JJ SMN_NNS did_VBD not_RB affect_VB or_CC disrupt_VB the_DT SMN-telomerase_NP interaction_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Although_IN incomplete_JJ RNA_NP digestion_NN cannot_MD be_VB ruled_VBN out_RP ,_, the_DT results_NNS suggest_VBP that_IN the_DT association_NN of_IN in_IN vitro_NN --_: synthesized_VBN SMN_NNS with_IN recombinant_JJ hTERT_NN is_VBZ mediated_VBN via_IN direct_JJ contact_NN with_IN hTERT_NN or_CC a_DT yeast_NN TERT-associated_JJ protein_NN ._SENT Figure_NP 1_CD |_SYM SMN_JJ associates_NNS with_IN hTERT_NN in_IN vitro_NN and_CC in_IN vivo_RB ._SENT SMN_JJ associates_NNS with_IN hTERT_NN in_IN vitro_NN and_CC in_IN vivo_RB ._SENT (_( A_NP )_) Human_NP telomerase_NN was_VBD reconstituted_VBN by_IN coexpression_NN of_IN GST-hTERT_NP and_CC hTR_NP in_IN S._NP cerevisiae_NNS as_IN previously_RB described_VBN ._SENT GST_NP (_( lanes_NNS 2_CD and_CC 5_CD )_) and_CC GST-hTERT/hTR_NP (_( lanes_NNS 3_CD and_CC 6_CD )_) were_VBD affinity-purified_VBN from_IN equal_JJ volumes_NNS of_IN yeast_NN extracts_VBZ and_CC incubated_VBN with_IN in_IN vitro_NN --_: translated_VBN [_SYM 35S]methionine-labeled_JJ luciferase_NN (_( lanes_NNS 1_CD --_: 3_LS )_) and_CC SMN_JJ (_( lanes_NNS 4_CD --_: 6_CD )_) ._SENT After_IN extensive_JJ washing_NN ,_, bound_JJ proteins_NNS were_VBD analyzed_VBN by_IN SDS-PAGE_NP and_CC autoradiography_NN ._SENT The_DT input_NN lanes_NNS (_( 1_CD and_CC 4_CD )_) show_VBP 5_CD %_NN of_IN the_DT RRL_NP lysate_NN used_VBN in_IN the_DT binding_JJ reaction_NN ._SENT Molecular_JJ mass_NN markers_NNS are_VBP indicated_VBN on_IN the_DT left_JJ (_( in_IN kilodaltons_NNS ,_, kDa_NP )_) ._SENT (_( B_LS )_) 293_CD cells_NNS were_VBD transiently_RB transfected_VBN with_IN a_DT DNA_NN construct_VB expressing_VBG FLAG-tagged_JJ hTERT_NN ._SENT At_IN 20_CD h_NN after_IN transfection_NN ,_, a_DT total_JJ cell_NN lysate_NNS was_VBD prepared_VBN and_CC subjected_VBN to_TO immunoprecipitation_NN (_( IP_NP )_) without_IN antibody_NN or_CC using_VBG anti-GST_NP ,_, anti-FLAG_NP ,_, anti-Sm_NN (_( Y12_NP )_) ,_, or_CC anti-TEP1_JJ ._SENT Immunoprecipitates_NNS were_VBD analyzed_VBN by_IN SDS-PAGE_NP and_CC Western_NP blotting_VBG for_IN endogenous_JJ SMN_NNS ._SENT The_DT lysate_NN lane_NN corresponds_VBZ to_TO 5_CD %_NN of_IN the_DT total_JJ cell_NN lysate_NNS used_VBN for_IN the_DT immunoprecipitation_NN ._SENT (_( C_LS )_) Nucleolar-enriched_JJ nuclear_JJ extracts_VBZ were_VBD prepared_VBN from_IN HeLa_NP cells_NNS and_CC subjected_VBN to_TO immunoprecipitation_NN (_( IP_NP )_) using_VBG anti-GST_NP ,_, anti-Sm_NN (_( Y12_NP )_) ,_, and_CC two_CD different_JJ affinity-purified_JJ hTERT_NN antibodies_NNS ._SENT Immunoprecipitates_NNS were_VBD analyzed_VBN by_IN SDS-PAGE_NP and_CC Western_NP blotting_VBG for_IN endogenous_JJ hTERT_NN (_( top_JJ )_) and_CC SMN_NP (_( bottom_NN )_) ._SENT Five_CD percent_NN of_IN the_DT cytosolic_JJ (_( C_NP )_) and_CC nucleolar-enriched_JJ nuclear_JJ (_( N_NP )_) extracts_VBZ were_VBD also_RB loaded_VBN ._SENT We_PP also_RB used_VBD transient_JJ expression_NN of_IN a_DT FLAG-tagged_JJ hTERT_NN protein_NN in_IN telomerase-positive_JJ 293_CD cells_NNS to_TO demonstrate_VB the_DT association_NN between_IN SMN_NN and_CC telomerase_NN ._SENT Total_JJ cell_NN extracts_VBZ from_IN 293_CD cells_NNS transiently_RB transfected_VBN with_IN a_DT FLAG-hTERT_NP construct_NN were_VBD subjected_VBN to_TO immunoprecipitation_NN using_VBG different_JJ antibodies_NNS and_CC analyzed_VBN by_IN immunoblotting_VBG with_IN a_DT mouse_NN monoclonal_NN anti-SMN_NN antibody_NN ._SENT As_IN previously_RB demonstrated_VBN ,_, an_DT antibody_NN specific_JJ to_TO the_DT Sm_NP protein_NN complex_NN efficiently_RB coimmunoprecipitated_JJ SMN_NN from_IN 293_CD cellular_JJ extracts_VBZ (_( Figure_NP B_NP ,_, lane_NN 5_CD )_) ._SENT The_DT precipitation_NN of_IN FLAG-tagged_JJ hTERT_NN using_VBG anti-FLAG_NN also_RB coimmunoprecipitated_JJ SMN_NN from_IN 293_CD cell_NN extracts_VBZ (_( Figure_NP B_NP ,_, lane_NN 4_CD )_) ._SENT An_DT antibody_NN specific_JJ to_TO a_DT telomerase-associated_JJ protein_NN (_( TEP1_NP )_) ,_, GST_JJ antibody_NN ,_, or_CC protein-A_NN --_: Sepharose_NP alone_RB did_VBD not_RB precipitate_VB the_DT SMN_JJ protein_NN (_( Figure_NP B_NP ,_, lanes_NNS 6_CD ,_, 3_CD ,_, and_CC 2_CD ,_, respectively_RB )_) ._SENT Nucleolar-enriched_JJ nuclear_JJ extracts_VBZ were_VBD prepared_VBN from_IN HeLa_NP cells_NNS to_TO determine_VB whether_IN an_DT endogenous_JJ SMN-hTERT_NP complex_NN exists_VBZ in_IN cells_NNS ._SENT The_DT SMN_NP protein_NN was_VBD found_VBN in_IN both_CC the_DT cytosolic_JJ and_CC nuclear_JJ extracts_VBZ (_( Figure_NP C_NP ,_, lanes_NNS 1_CD and_CC 2_CD )_) ,_, as_RB expected_VBN from_IN its_PP$ previously_RB determined_VBN subcellular_JJ localization_NN ._SENT Confirming_VBG the_DT efficiency_NN of_IN our_PP$ nuclear_JJ extract_NN preparation_NN ,_, the_DT hTERT_NN protein_NN was_VBD primarily_RB nuclear_JJ (_( Figure_NP C_NP ,_, lanes_NNS 1_CD and_CC 2_CD )_) ,_, in_IN agreement_NN with_IN the_DT previous_JJ immunofluorescence_NN analysis_NN of_IN hTERT_NP and_CC mTERT_NP ._SENT Proteins_NNS from_IN the_DT nuclear_JJ extracts_VBZ were_VBD subjected_VBN to_TO immunoprecipitation_NN using_VBG the_DT Sm_NN protein_NN --_: specific_JJ antibody_NN (_( Y12_NP )_) ,_, an_DT affinity-purified_JJ hTERT_NN antibody_NN ,_, and_CC a_DT GST-specific_JJ antibody_NN as_IN a_DT negative_JJ control_NN ._SENT After_IN extensive_JJ washing_NN of_IN the_DT antibody-coated_JJ beads_NNS ,_, the_DT immunoprecipitated_JJ proteins_NNS were_VBD analyzed_VBN for_IN recovery_NN of_IN SMN_NP and_CC hTERT_NP as_RB determined_VBD by_IN Western_NP blotting_VBG with_IN antibodies_NNS specific_JJ for_IN the_DT respective_JJ proteins_NNS ._SENT As_IN demonstrated_VBN in_IN Figure_NP B_NP ,_, immunoprecipitation_NN performed_VBN with_IN the_DT Y12_NP antibody_NN coprecipitated_VBD SMN_NN from_IN HeLa_NP cell_NN nuclear_JJ extracts_VBZ ,_, but_CC not_RB the_DT hTERT_NN protein_NN (_( Figure_NP C_NP ,_, lane_NN 4_CD )_) ._SENT hTERT-specific_JJ immunoprecipitation_NN also_RB recovered_VBD SMN_NN from_IN the_DT HeLa_NP nuclear_JJ extracts_VBZ (_( lane_NN 5_CD )_) ._SENT The_DT coimmunopurification_NN of_IN SMN_NP and_CC hTERT_NP was_VBD also_RB confirmed_VBN using_VBG a_DT different_JJ affinity-purified_JJ hTERT_NN antibody_NN (_( Figure_NP C_NP ,_, lane_NN 6_CD )_) ._SENT As_IN a_DT control_NN ,_, neither_CC SMN_NP nor_CC hTERT_NP was_VBD present_JJ in_IN anti-GST_NP immunoprecipitates_NNS (_( lane_NN 3_CD )_) ._SENT We_PP conclude_VBP that_IN hTERT_NP and_CC SMN_NP can_MD associate_VB in_IN vitro_NN and_CC in_IN human_JJ cells_NNS ._SENT SMN_NP Is_NP Associated_NP with_IN Catalytically_NP Active_NP Human_NP Telomerase_NP |_SYM We_PP used_VBD transient_JJ transfection_NN experiments_NNS to_TO investigate_VB whether_IN SMN_NN is_VBZ associated_VBN with_IN active_JJ human_JJ telomerase_NN ._SENT A_DT Myc-tagged_JJ version_NN of_IN SMN_NP and_CC FLAG-hTERT_NP were_VBD transiently_RB expressed_VBN in_IN human_JJ 293_CD cells_NNS ,_, and_CC total_JJ cell_NN lysates_NNS were_VBD prepared_VBN for_IN immunoprecipitations_NNS using_VBG either_DT Myc_NP or_CC FLAG_NP antibodies_NNS ._SENT As_IN a_DT control_NN ,_, a_DT lysate_NN from_IN mock-transfected_JJ cells_NNS was_VBD used_VBN ._SENT TRAP_NN assays_NNS demonstrated_VBD that_IN equal_JJ levels_NNS of_IN telomerase_NN activity_NN were_VBD present_JJ in_IN the_DT different_JJ total_JJ cell_NN lysates_NNS before_IN immunopurification_NN (_( Figure_NP ,_, lanes_NNS 1_CD --_: 3_LS )_) ._SENT As_IN previously_RB demonstrated_VBN ,_, FLAG_NP antibody_NN resin_NN precipitated_VBD the_DT FLAG-hTERT_NP protein_NN (_( data_NNS not_RB shown_VBN )_) and_CC human_JJ telomerase_NN activity_NN from_IN the_DT FLAG-hTERT_NP --_: containing_VBG extracts_VBZ (_( Figure_NP ,_, lane_NN 8_CD )_) ._SENT However_RB ,_, no_DT telomerase_NN activity_NN was_VBD present_JJ on_IN the_DT FLAG-antibody_NP resin_NN incubated_VBN with_IN Myc-SMN_NN --_: containing_VBG extracts_VBZ (_( lane_NN 7_CD )_) ._SENT Telomerase_NN activity_NN (_( lane_NN 5_CD )_) was_VBD also_RB recovered_VBN from_IN Myc-antibody_NP resin_NN prepared_VBN from_IN lysates_NNS containing_VBG the_DT Myc-SMN_JJ protein_NN ,_, but_CC not_RB from_IN anti-Myc_NN immunoprecipitates_NNS prepared_VBN from_IN lysates_NNS of_IN mock-transfected_JJ and_CC FLAG-hTERT_NP --_: transfected_JJ cells_NNS (_( lanes_NNS 4_CD and_CC 6_CD ,_, respectively_RB )_) ._SENT Similar_JJ results_NNS were_VBD observed_VBN using_VBG HeLa_NP cells_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT These_DT results_NNS indicate_VBP that_IN SMN_JJ associates_NNS with_IN a_DT fully_RB assembled_VBN and_CC catalytically_RB active_JJ telomerase_NN RNP_NP ._SENT Figure_NP 2_CD |_SYM SMN_JJ associates_NNS with_IN catalytically_RB active_JJ telomerase_NN ._SENT SMN_JJ associates_NNS with_IN catalytically_RB active_JJ telomerase_NN ._SENT 293_CD cells_NNS were_VBD transiently_RB transfected_VBN with_IN DNA_NN constructs_NNS expressing_VBG Myc-tagged_JJ SMN_NNS (_( lanes_NNS 2_CD ,_, 5_CD ,_, and_CC 7_CD )_) ,_, FLAG-tagged_JJ hTERT_NN (_( lanes_NNS 3_CD ,_, 6_CD ,_, and_CC 8_CD )_) ,_, or_CC with_IN vector_NN alone_RB (_( mock_VB ;_: lanes_NNS 1_CD and_CC 4_CD )_) ._SENT Total_JJ cell_NN lysates_NNS were_VBD prepared_VBN and_CC subjected_VBN to_TO immunoprecipitation_NN using_VBG either_DT anti-Myc_NN (_( lanes_NNS 4_CD --_: 6_CD )_) or_CC anti-FLAG_NN (_( lanes_NNS 7_CD and_CC 8_CD )_) ._SENT Immunoprecipitates_NNS were_VBD analyzed_VBN for_IN telomerase_NN activity_NN by_IN the_DT TRAP_NP assay_NN ._SENT Of_IN the_DT total_JJ cell_NN lysates_NNS (_( lanes_NNS 1_CD --_: 3_LS )_) ,_, 0.5_CD %_NN were_VBD also_RB assayed_VBN for_IN telomerase_NN activity_NN ._SENT The_DT Sm_NP Protein_NP Complex_NP Is_VBZ Not_RB Associated_NP with_IN Active_NP Human_NP Telomerase_NP and_CC hTR_NNS |_SYM The_DT Sm_NN proteins_NNS form_VBP an_DT RNA-binding_NP complex_NN that_WDT interacts_VBZ with_IN a_DT specific_JJ region_NN of_IN UsnRNAs_NP ._SENT Direct_JJ interactions_NNS between_IN SMN_NN and_CC specific_JJ members_NNS of_IN the_DT Sm_NP proteins_NNS are_VBP thought_VBN to_TO recruit_VB the_DT SMN_JJ complex_NN to_TO the_DT Sm-snRNA_NP complex_NN ._SENT Interestingly_RB ,_, the_DT S._NP cerevisiae_NNS telomerase_JJ RNA_NP subunit_NN ,_, TLC1_NP ,_, contains_VBZ an_DT Sm_NN protein_NN --_: binding_JJ site_NN ,_, as_RB determined_VBN by_IN the_DT coimmunoprecipitation_NN of_IN the_DT TLC1_NP RNA_NP and_CC yeast_NN telomerase_NN activity_NN with_IN epitope-tagged_JJ versions_NNS of_IN the_DT SmD1_NP and_CC SmD3_NP proteins_NNS ._SENT Myc-tagged_JJ versions_NNS of_IN the_DT human_JJ SmB_NP ,_, SmD1_NP ,_, and_CC SmD3_NP proteins_NNS were_VBD used_VBN to_TO examine_VB whether_IN the_DT association_NN of_IN SMN_NN with_IN telomerase_NN could_MD be_VB mediated_VBN by_IN the_DT involvement_NN of_IN the_DT Sm_NP protein_NN complex_NN in_IN human_JJ telomerase_NN biogenesis_NN ._SENT Addition_NN of_IN the_DT Myc_NP epitope_NN to_TO the_DT N-terminus_NN of_IN the_DT SmB_NP ,_, D1_NP ,_, and_CC D3_NP proteins_NNS did_VBD not_RB affect_VB their_PP$ function_NN ,_, as_RB determined_VBN by_IN their_PP$ ability_NN to_TO coimmunoprecipitate_VB SMN_NN and_CC by_IN immunofluorescence_NN analysis_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Constructs_NNS expressing_VBG the_DT Myc-SmB_NP ,_, Myc-SmD1_NP ,_, and_CC Myc-SmD3_NP proteins_NNS were_VBD transfected_VBN into_IN human_JJ 293_CD cells_NNS ,_, and_CC total_JJ cell_NN extracts_VBZ were_VBD prepared_VBN for_IN immunopurification_NN using_VBG the_DT Myc_NP antibody_NN ._SENT As_RB was_VBD previously_RB shown_VBN ,_, Myc-antibody_NP resin_NN incubated_VBN with_IN Myc-SMN_NN --_: containing_VBG extracts_VBZ recovers_VBZ telomerase_NN activity_NN (_( Figure_NP ,_, lane_NN 9_CD )_) ._SENT However_RB ,_, immunoprecipitations_NNS performed_VBD using_VBG the_DT Myc_NP antibody_NN and_CC prepared_VBN from_IN either_CC the_DT Myc-SmB_NN --_: ,_, Myc-SmD1_JJ --_: ,_, or_CC Myc-SmD3_NP --_: containing_VBG extracts_VBZ did_VBD not_RB recover_VB levels_NNS of_IN human_JJ telomerase_NN activity_NN (_( Figure_NP ,_, lanes_NNS 10_CD --_: 12_CD ,_, respectively_RB )_) significantly_RB higher_JJR than_IN background_NN (_( lane_NN 8_CD )_) ._SENT Western_JJ blot_NN analysis_NN of_IN the_DT immunoprecipitated_JJ proteins_NNS (_( Figure_NP A_NP ,_, bottom_NN )_) revealed_VBD that_IN the_DT myc-tagged_JJ Sm_NN proteins_NNS were_VBD expressed_VBN and_CC immunoprecipitated_VBN to_TO considerably_RB higher_JJR levels_NNS than_IN myc-tagged_JJ SMN_NNS ,_, yet_RB only_RB myc-SMN_JJ copurified_JJ human_JJ telomerase_NN activity_NN ._SENT As_IN a_DT control_NN ,_, anti-FLAG_NN antibody_NN efficiently_RB precipitated_VBD telomerase_NN activity_NN from_IN lysates_NNS prepared_VBN from_IN FLAG-hTERT_NP --_: transfected_JJ cells_NNS (_( lane_NN 13_CD )_) ._SENT These_DT results_NNS ,_, in_IN addition_NN to_TO the_DT absence_NN of_IN hTERT_NN in_IN Y12_JJ immunoprecipitates_NNS (_( Figure_NP C_NP )_) ,_, indicate_VBP that_IN the_DT Sm_NP protein_NN complex_NN is_VBZ not_RB associated_VBN with_IN the_DT human_JJ telomerase_NN RNP_NN and_CC suggest_VBP that_IN Sm_NP proteins_NNS do_VBP not_RB mediate_VB the_DT SMN-telomerase_NP association_NN ._SENT Figure_NP 3_CD |_SYM The_DT hTR_NN and_CC telomerase_NN activity_NN are_VBP not_RB associated_VBN with_IN the_DT Sm_NP protein_NN complex_NN ._SENT The_DT hTR_NN and_CC telomerase_NN activity_NN are_VBP not_RB associated_VBN with_IN the_DT Sm_NP protein_NN complex_NN ._SENT (_( A_NP )_) 293_CD cells_NNS were_VBD transiently_RB transfected_VBN with_IN DNA_NN constructs_NNS expressing_VBG Myc-SMN_JJ (_( lanes_NNS 3_CD and_CC 9_CD )_) ,_, Myc-SmB_NP (_( lanes_NNS 4_CD and_CC 10_CD )_) ,_, Myc-SmD1_JJ (_( lanes_NNS 5_CD and_CC 11_CD )_) ,_, Myc-SmD3_NP (_( lanes_NNS 6_CD and_CC 12_CD )_) ,_, FLAG-hTERT_NP (_( lanes_NNS 7_CD and_CC 13_CD )_) ,_, or_CC with_IN vector_NN alone_RB (_( mock_VB ;_: lanes_NNS 2_CD and_CC 8_CD )_) ._SENT At_IN 20_CD h_NN after_IN transfection_NN ,_, total_JJ cell_NN lysates_NNS were_VBD prepared_VBN and_CC subjected_VBN to_TO immunoprecipitation_NN using_VBG either_DT anti-Myc_NN (_( lanes_NNS 8_CD --_: 12_LS )_) or_CC anti-FLAG_NP (_( lane_NN 13_CD )_) ._SENT Immunoprecipitates_NNS were_VBD analyzed_VBN for_IN telomerase_NN activity_NN by_IN the_DT TRAP_NP assay_NN (_( top_JJ )_) and_CC for_IN protein_NN content_NN by_IN Western_NP blotting_VBG (_( WB_NP )_) using_VBG anti-myc_NN (_( bottom_NN )_) ._SENT Of_IN the_DT total_JJ cell_NN lysates_NNS (_( lanes_NNS 2_CD --_: 7_CD )_) or_CC lysis_NN buffer_NN (_( lane_NN 1_CD )_) ,_, 1_CD %_NN were_VBD analyzed_VBN for_IN telomerase_NN activity_NN ._SENT (_( B_LS )_) A_DT total_JJ cell_NN lysate_NN from_IN HeLa_NP cells_NNS was_VBD prepared_VBN and_CC subjected_VBN to_TO immunoprecipitation_NN using_VBG anti-Sm_NN (_( Y12-lane_NP 2_CD )_) ,_, affinity-purified_JJ anti-hTERT_NP (_( lane_NN 3_CD )_) ,_, anti-TMG_NP (_( lane_NN 4_CD )_) ,_, or_CC anti-GST_NP (_( lane_NN 5_CD )_) ._SENT Immunoprecipitates_NNS were_VBD analyzed_VBN by_IN denaturing_VBG PAGE_NP and_CC Northern_NP blotting_VBG for_IN endogenous_JJ hTR_NN (_( top_JJ )_) ,_, U1_NP snRNA_NP (_( middle_NN )_) ,_, and_CC U6_NP snRNA_NP (_( bottom_NN )_) ._SENT The_DT input_NN lane_NN (_( lane_NN 1_CD )_) was_VBD loaded_VBN with_IN 2.5_CD %_NN of_IN the_DT total_JJ RNA_NP extracted_VBD from_IN the_DT HeLa_NP total_JJ cell_NN lysate_NNS ._SENT For_IN hTR_NN ,_, exposure_NN time_NN was_VBD three_CD times_NNS longer_RBR than_IN for_IN U1_NP and_CC U6_NP ._SENT To_TO further_RBR investigate_VB whether_IN the_DT Sm_NP protein_NN complex_NN is_VBZ involved_VBN in_IN human_JJ telomerase_NN biogenesis_NN ,_, we_PP determined_VBD whether_IN endogenous_JJ hTR_NN from_IN HeLa_NP total_JJ cell_NN extracts_VBZ copurifies_NNS with_IN the_DT Sm_NP complex_NN using_VBG the_DT Y12_NP antibody_NN ._SENT As_IN previously_RB demonstrated_VBN ,_, endogenous_JJ U1_NP and_CC U6_NP snRNAs_NNS are_VBP coprecipitated_VBN with_IN Sm_NP proteins_NNS using_VBG the_DT Y12_NP antibody_NN (_( Figure_NP B_NP ,_, lane_NN 1_CD )_) ._SENT However_RB ,_, the_DT Y12_NP antibody_NN did_VBD not_RB coimmunoprecipitate_VB hTR_NP (_( Figure_NP B_NP ,_, lane_NN 2_CD )_) ._SENT hTERT-associated_JJ hTR_NN was_VBD coprecipitated_VBN using_VBG an_DT affinity-purified_JJ hTERT_NN antibody_NN (_( Figure_NP B_NP ,_, lane_NN 3_CD )_) ,_, whereas_IN an_DT anti-GST_NP immunoprecipitation_NN did_VBD not_RB recover_VB U1_NP ,_, U6_NP ,_, or_CC hTR_NP (_( Figure_NP B_NP ,_, lane_NN 5_CD )_) ._SENT We_PP also_RB determined_VBD whether_IN a_DT subpopulation_NN of_IN the_DT hTR_NN contains_VBZ a_DT TMG_NP cap_NN structure_NN as_RB was_VBD previously_RB shown_VBN for_IN the_DT yeast_NN telomerase_NN RNA_NP ._SENT This_DT type_NN of_IN hypermethylated_JJ 5'-cap_NN structure_NN is_VBZ a_DT well-known_JJ characteristic_NN of_IN some_DT spliceosomal_JJ snRNAs_NNS ,_, such_JJ as_IN U1_NP ,_, U2_NP ,_, U4_NP ,_, and_CC U5_NP ._SENT HeLa_NP total_JJ cell_NN lysates_NNS were_VBD subjected_VBN to_TO immunoprecipitation_NN using_VBG a_DT TMG-specific_JJ monoclonal_NN antibody_NN ,_, and_CC the_DT copurified_JJ RNAs_NP were_VBD analyzed_VBN by_IN Northern_NP blotting_VBG ._SENT Both_DT U1_NP and_CC U2_NP snRNAs_NNS were_VBD recovered_VBN from_IN the_DT anti-TMG_NN immunoprecipitate_NN (_( Figure_NP B_NP ,_, lane_NN 4_CD and_CC data_NNS not_RB shown_VBN )_) ,_, whereas_IN the_DT presence_NN of_IN hTR_NN in_IN TMG-specific_JJ immunoprecipitates_NNS was_VBD undetectable_JJ (_( Figure_NP B_NP ,_, lane_NN 4_CD )_) ._SENT Similarly_RB ,_, U6_NP snRNA_NP was_VBD not_RB coimmunoprecipitated_VBN by_IN the_DT TMG-specific_JJ antibody_NN (_( lane_NN 4_CD )_) and_CC was_VBD used_VBN as_IN a_DT negative_JJ control_NN because_IN it_PP does_VBZ not_RB have_VB a_DT 5'-TMG_JJ cap_NN structure_NN ._SENT In_IN conclusion_NN ,_, these_DT results_NNS indicate_VBP that_IN the_DT Sm_NN proteins_NNS ,_, whether_IN endogenous_JJ or_CC transiently_RB overexpressed_JJ ,_, associate_NN neither_CC with_IN hTR_NN nor_CC with_IN the_DT catalytically_RB active_JJ human_JJ telomerase_NN RNP_NP ._SENT Our_PP$ results_NNS further_RBR suggest_VB that_DT hTR_NN does_VBZ not_RB acquire_VB a_DT 5'-TMG_JJ cap._JJ Expression_NN of_IN a_DT Dominant-Negative_NP Version_NP of_IN SMN_NP (_( SMNDeltaN27_NP )_) Perturbs_VBZ the_DT Subcellular_JJ Localization_NN of_IN hTERT_NP |_SYM The_DT SMN_JJ protein_NN is_VBZ present_JJ in_IN the_DT cytoplasm_NN as_IN well_RB as_RB in_IN the_DT nucleus_NN of_IN cells_NNS ,_, where_WRB it_PP is_VBZ known_VBN to_TO concentrate_VB in_IN nuclear_JJ structures_NNS such_JJ as_IN gems_NNS ,_, CBs_NP ,_, and_CC nucleoli_NNS ._SENT A_DT previous_JJ study_NN characterizing_VBG a_DT dominant-negative_JJ mutant_NN of_IN SMN_NNS lacking_VBG its_PP$ first_JJ N-terminal_NP 27_CD amino_NN acids_NNS (_( SMNDeltaN27_NP )_) revealed_VBD that_IN this_DT mutant_JJ protein_NN causes_VBZ the_DT reorganization_NN of_IN snRNPs_NNS in_IN the_DT nucleus_NN and_CC in_IN the_DT cytoplasm_NN and_CC also_RB negatively_RB affects_VBZ pre-mRNA_NNS splicing_VBG in_IN vitro_NN ._SENT This_DT SMN_JJ mutant_JJ protein_NN was_VBD also_RB used_VBN to_TO demonstrate_VB the_DT functional_JJ interaction_NN between_IN SMN_NP and_CC the_DT RNA_NP polymerase_NN II_NP complex_NN as_IN well_RB as_RB with_IN the_DT snoRNP_NN proteins_VBZ fibrillarin_NN and_CC hGAR1_JJ ._SENT We_PP generated_VBD SMNDeltaN27_JJ to_TO investigate_VB the_DT effect_NN of_IN this_DT dominant-negative_JJ mutant_JJ SMN_NN on_IN hTERT_JJ cellular_JJ localization_NN ._SENT Indirect_JJ immunofluorescence_NN with_IN the_DT Myc_NP antibody_NN was_VBD used_VBN to_TO detect_VB the_DT Myc-SMN_NN and_CC Myc-SMNDeltaN27_JJ proteins_NNS in_IN transfected_JJ HeLa_NP cells_NNS ._SENT The_DT Myc-SMN_JJ protein_NN localized_VBN in_IN the_DT cytoplasm_NN and_CC in_IN the_DT nucleus_NN ,_, where_WRB it_PP accumulated_VBN in_IN gems_NNS and_CC CBs_NP (_( Figure_NP ,_, A_NP and_CC B_NP ,_, c_LS )_) ._SENT When_WRB the_DT Myc-SMN_JJ construct_NN was_VBD cotransfected_VBN with_IN a_DT plasmid_NN expressing_VBG a_DT yellow_JJ fluorescent_JJ protein_NN (YFP)-SmB_NN fusion_NN ,_, Myc-SMN_NP and_CC YFP-SmB_NP colocalized_VBD in_IN gems_NNS and_CC CBs_NP (_( Figure_NP A_NP ,_, a_DT --_: d_LS )_) ,_, as_RB previously_RB reported_VBN ._SENT In_IN cells_NNS transfected_VBN with_IN Myc-SMNDeltaN27_JJ ,_, the_DT mutant_JJ protein_NN accumulated_VBN in_IN large_JJ cytoplasmic_JJ bodies_NNS that_WDT partially_RB redistributed_VBD the_DT YFP-SmB_NP fusion_NN (_( Figure_NP A_NP ,_, e_NN --_: h_NN )_) ._SENT In_IN contrast_NN ,_, the_DT YFP-SmB_NP fusion_NN protein_NN was_VBD barely_RB detectable_JJ in_IN the_DT cytoplasm_NN of_IN Myc-SMN_JJ transfected_JJ cells_NNS (_( Figure_NP A_NP ,_, b_LS )_) and_CC untransfected_JJ cells_NNS (_( data_NNS not_RB shown_VBN )_) ,_, consistent_JJ with_IN the_DT localization_NN of_IN endogenous_JJ Sm_NN proteins_NNS as_RB detected_VBD using_VBG the_DT Sm-specific_NP Y12_NP antibody_NN ._SENT Similar_JJ results_NNS were_VBD obtained_VBN when_WRB a_DT YFP-SmD1_JJ fusion_NN was_VBD used_VBN (_( data_NNS not_RB shown_VBN )_) ,_, in_IN agreement_NN with_IN the_DT observations_NNS that_IN a_DT mutant_NN of_IN SMN_NNS lacking_VBG the_DT first_JJ 27_CD amino_NN acids_NNS causes_VBZ a_DT reorganization_NN of_IN Sm_NP snRNPs_NNS proteins_NNS ._SENT Figure_NP 4_CD |_SYM The_DT expression_NN of_IN a_DT dominant-negative_JJ mutant_NN of_IN SMN_NP (_( SMNDeltaN27_NP )_) perturbs_VBZ the_DT nuclear_JJ localization_NN of_IN hTERT_NN ._SENT The_DT expression_NN of_IN a_DT dominant-negative_JJ mutant_NN of_IN SMN_NP (_( SMNDeltaN27_NP )_) perturbs_VBZ the_DT nuclear_JJ localization_NN of_IN hTERT_NP ._SENT (_( A_NP )_) HeLa_NP cells_NNS were_VBD transiently_RB cotransfected_JJ with_IN DNA_NN constructs_NNS expressing_VBG either_DT Myc-SMN_NP and_CC YFP-SmB_NP (_( a_DT --_: d_LS )_) or_CC Myc-SMNDeltaN27_NP and_CC YFP-SmB_NP (_( e_NP --_: h_NN )_) ._SENT The_DT fixed_VBN and_CC permeabilized_VBN cells_NNS were_VBD stained_VBN for_IN Myc-SMN_JJ (_( c_LS )_) and_CC Myc-SMNDeltaN27_JJ (_( g_NN )_) using_VBG anti-Myc_NN ._SENT DNA_NP stained_VBD with_IN DAPI_NP shows_VBZ the_DT nucleus_NN of_IN each_DT cell_NN (_( a_DT and_CC e_LS )_) ._SENT Images_NNS b_NN and_CC c_NN ,_, and_CC f_NN and_CC g_NN ,_, are_VBP merged_VBN to_TO form_VB d_NN and_CC h_NN ,_, respectively_RB ._SENT (_( B_NP )_) HeLa_NP cells_NNS were_VBD transiently_RB cotransfected_JJ with_IN DNA_NN constructs_NNS expressing_VBG either_DT Myc-SMN_NP and_CC GFP-hTERT_NP (_( a_DT --_: d_LS )_) or_CC Myc-SMNDeltaN27_NP and_CC GFP-hTERT_NP (_( e_NP --_: l_NN )_) ._SENT The_DT fixed_VBN and_CC permeabilized_VBN cells_NNS were_VBD stained_VBN for_IN Myc-SMN_JJ (_( c_LS )_) and_CC Myc-SMNDeltaN27_JJ (_( g_NN and_CC k_NN )_) using_VBG anti-Myc_NN ._SENT DNA_NP stained_VBD with_IN DAPI_NP shows_VBZ the_DT nucleus_NN of_IN each_DT cell_NN (_( a_DT ,_, e_NN ,_, and_CC i_NP )_) ._SENT Images_NNS b_NN and_CC c_NN ,_, f_NN and_CC g_NN ,_, and_CC j_NN and_CC k_NN are_VBP merged_VBN to_TO form_VB d_NN ,_, h_NN ,_, and_CC l_NN ,_, respectively_RB ._SENT The_DT arrows_NNS point_VBP to_TO the_DT nuclear_JJ gems_NNS and_CC the_DT arrowheads_NNS to_TO the_DT SMNDeltaN27-induced_JJ cytoplasmic_JJ accumulations_NNS ._SENT Bar_NP ,_, 12_CD mum_NN ._SENT We_PP used_VBD GFP-tagged_JJ hTERT_NN to_TO monitor_VB the_DT steady-state_NN subcellular_JJ localization_NN of_IN hTERT_NN ._SENT Addition_NN of_IN GFP_NP to_TO the_DT N-terminus_NP of_IN hTERT_NP did_VBD not_RB alter_VB its_PP$ catalytic_JJ function_NN ,_, because_IN the_DT GFP-hTERT_NP fusion_NN reconstituted_VBD human_JJ telomerase_NN activity_NN when_WRB expressed_VBN in_IN telomerase-negative_JJ human_JJ fibroblasts_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT The_DT GFP-hTERT_NP fusion_NN protein_NN showed_VBD a_DT diffuse_JJ nucleoplasmic_JJ distribution_NN both_CC in_IN untransfected_JJ (_( data_NNS not_RB shown_VBN )_) and_CC in_IN Myc-SMN_NN --_: transfected_JJ HeLa_NP cells_NNS (_( Figure_NN B_NN ,_, b_LS )_) ,_, consistent_JJ with_IN previous_JJ reports_NNS of_IN TERT_NP localization_NN ._SENT GFP-tagged_NP hTERT_NP did_VBD not_RB specifically_RB colocalize_VB with_IN Myc-SMN_NN in_IN gems_NNS and_CC CBs_NP (_( Figure_NP B_NP ,_, a_DT --_: d_LS )_) but_CC did_VBD frequently_RB localize_VB to_TO the_DT nucleolus_NN of_IN transfected_JJ cells_NNS (_( Figure_NP B_NP and_CC data_NNS not_RB shown_VBN )_) ._SENT GFP-hTERT_NP expressed_VBD in_IN Myc-SMNDeltaN27_JJ --_: transfected_JJ cells_NNS accumulated_VBN prominently_RB in_IN the_DT cytoplasm_NN in_IN structures_NNS that_WDT colocalized_VBD with_IN the_DT Myc-SMNDeltaN27_JJ protein_NN (_( Figure_NP B_NP ,_, e_NN --_: l_NN )_) ,_, in_IN striking_JJ contrast_NN to_TO the_DT restricted_JJ and_CC diffuse_JJ nucleoplasmic_JJ localization_NN of_IN hTERT_NN in_IN Myc-SMN_NN --_: transfected_JJ and_CC untransfected_JJ cells_NNS ._SENT The_DT colocalization_NN of_IN hTERT_NN and_CC Myc-SMNDeltaN27_JJ was_VBD also_RB observed_VBN in_IN the_DT nucleus_NN ,_, where_WRB GFP-hTERT_NP accumulated_VBN in_IN gems_NNS and_CC CBs_NP (_( Figure_NP B_NP ,_, f_NN --_: h_NN )_) ._SENT The_DT observation_NN that_IN hTERT_JJ subcellular_JJ localization_NN is_VBZ affected_VBN by_IN expression_NN of_IN SMNDeltaN27_NP suggests_VBZ a_DT functional_JJ relationship_NN between_IN the_DT SMN_JJ complex_NN and_CC human_JJ telomerase_NN ._SENT SMNDeltaN27_NP Affects_NPS Human_NP Telomerase_NP Reconstitution_NP In_IN Vitro_NP |_SYM Coexpression_NN of_IN hTERT_NN and_CC hTR_NN reconstitutes_VBZ human_JJ telomerase_NN activity_NN in_IN RRLs_NP ._SENT Studies_NNS of_IN human_JJ and_CC Tetrahymena_NP telomerase_NN suggest_VBP that_IN proteins_NNS present_VB in_IN reticulocyte_NN extracts_VBZ may_MD be_VB involved_VBN in_IN reconstitution_NN of_IN telomerase_NN assembly_NN and/or_CC activity_NN ._SENT Western_JJ blot_NN analysis_NN of_IN crude_JJ RRL_NP extracts_VBZ using_VBG a_DT monoclonal_NN SMN_NN antibody_NN revealed_VBD the_DT presence_NN of_IN a_DT single_JJ 38-kDa_JJ protein_NN (_( data_NNS not_RB shown_VBN )_) ,_, suggesting_VBG the_DT presence_NN of_IN rabbit_NN SMN_NNS in_IN reticulocyte_NN lysates_NNS ._SENT This_DT latter_JJ observation_NN and_CC the_DT profound_JJ effects_NNS of_IN SMNDeltaN27_JJ on_IN hTERT_JJ subcellular_JJ localization_NN led_VBD us_PP to_TO examine_VB whether_IN expression_NN of_IN SMNDeltaN27_JJ in_IN RRL_NP would_MD affect_VB the_DT reconstitution_NN of_IN human_JJ telomerase_NN activity_NN ._SENT In_IN vitro_NN --_: transcribed_VBN hTR_NN was_VBD added_VBN to_TO RRL_NP programmed_VBN to_TO express_VB hTERT_NN alone_RB or_CC to_TO coexpress_VB hTERT_NN with_IN SmB_NP ,_, wild-type_JJ human_JJ SMN_NN ,_, or_CC the_DT SMNDeltaN27_JJ mutant_NN ._SENT Protein_NN synthesis_NN was_VBD allowed_VBN to_TO proceed_VB for_IN different_JJ lengths_NNS of_IN time_NN ,_, followed_VBN by_IN analysis_NN of_IN telomerase_NN activity_NN by_IN TRAP_NP ._SENT Human_JJ telomerase_NN activity_NN was_VBD undetectable_JJ after_IN 30_CD min_NN ,_, whether_IN hTERT_NN was_VBD expressed_VBN alone_RB or_CC with_IN another_DT protein_NN (_( Figure_NP A_NP ,_, lanes_NNS 1_CD ,_, 4_CD ,_, 7_CD ,_, and_CC 10_CD )_) ._SENT At_IN 60_CD min_NN ,_, robust_JJ telomerase_NN activity_NN was_VBD observed_VBN in_IN the_DT control_NN RRL_NN reaction_NN ,_, in_IN which_WDT hTERT_NN was_VBD expressed_VBN alone_RB (_( lane_NN 2_CD )_) ._SENT Telomerase_NN activity_NN was_VBD also_RB detected_VBN when_WRB SmB_NP or_CC SMN_NP was_VBD coexpressed_VBN with_IN hTERT_NN (_( lanes_NNS 5_CD and_CC 8_CD )_) ._SENT Lower_JJR levels_NNS of_IN telomerase_NN activity_NN were_VBD observed_VBN in_IN RRL_NP reactions_NNS coexpressing_VBG hTERT_NN and_CC SmB/SMN_NN than_IN in_IN the_DT control_NN reaction_NN (_( compare_VB lanes_NNS 5_CD and_CC 8_CD with_IN lane_NN 2_CD )_) because_IN of_IN the_DT lower_JJR levels_NNS of_IN hTERT_NN protein_NN synthesized_VBD when_WRB additional_JJ DNA_NN is_VBZ present_JJ in_IN the_DT RRL_NP reaction_NN (_( Figure_NP B_NP and_CC data_NNS not_RB shown_VBN )_) ._SENT Human_JJ telomerase_NN activity_NN reconstituted_VBN after_IN 60_CD min_NN was_VBD barely_RB detectable_JJ from_IN the_DT reaction_NN that_IN coexpressed_JJ hTERT_NN and_CC SMNDeltaN27_JJ (_( lane_NN 11_CD )_) ._SENT Similarly_RB ,_, after_IN 90_CD min_NN ,_, the_DT amount_NN of_IN telomerase_NN activity_NN reconstituted_VBN in_IN the_DT SMNDeltaN27-programmed_NP RRL_NP was_VBD considerably_RB lower_JJR than_IN in_IN SmB-_NP and_CC SMN-containing_NP RRLs_NP (_( compare_VB lane_JJ 12_CD with_IN lanes_NNS 6_CD and_CC 9_CD )_) ._SENT As_RB can_MD be_VB seen_VBN in_IN Figure_NP B_NP ,_, these_DT differences_NNS were_VBD not_RB attributed_VBN to_TO drastically_RB different_JJ levels_NNS of_IN hTERT_NN protein_NN (_( lanes_NNS 2_CD --_: 4_LS )_) ._SENT Telomerase_NN activity_NN was_VBD similar_JJ to_TO the_DT results_NNS seen_VBN in_IN Figure_NP A_NP when_WRB luciferase_NN was_VBD expressed_VBN with_IN hTERT_NN rather_RB than_IN SmB_NP (_( data_NN not_RB shown_VBN )_) ._SENT The_DT decreased_VBN efficiency_NN of_IN human_JJ telomerase_NN reconstitution_NN when_WRB SMNDeltaN27_NP is_VBZ expressed_VBN in_IN RRL_NP was_VBD reproduced_VBN in_IN three_CD independent_JJ experiments_NNS ._SENT Telomerase_JJ activity_NN levels_NNS were_VBD quantified_VBN from_IN the_DT three_CD independent_JJ experiments_NNS and_CC averaged_VBD ,_, and_CC a_DT percentage_NN was_VBD calculated_VBN relative_JJ to_TO the_DT levels_NNS of_IN activity_NN reconstituted_VBN in_IN the_DT control_NN RRL_NN reaction_NN ,_, in_IN which_WDT hTERT_NN was_VBD expressed_VBN alone_RB (_( Figure_NP C_NP )_) ._SENT These_DT results_NNS indicate_VBP that_IN a_DT previously_RB characterized_VBN dominant-negative_JJ SMN_NNS mutant_JJ ,_, SMNDeltaN27_JJ ,_, significantly_RB decreases_VBZ the_DT efficiency_NN of_IN human_JJ telomerase_NN reconstitution_NN in_IN vitro_NN ._SENT Figure_NP 5_CD |_SYM Expression_NN of_IN SMNDeltaN27_JJ decreases_NNS human_JJ telomerase_NN activity_NN reconstitution_NN in_IN RRLs_NP ._SENT Expression_NN of_IN SMNDeltaN27_JJ decreases_NNS human_JJ telomerase_NN activity_NN reconstitution_NN in_IN RRLs_NP ._SENT (_( A_NP )_) hTERT_NN was_VBD synthesized_VBN in_IN RRL_NP in_IN the_DT presence_NN of_IN hTR_NN ,_, [_SYM 35S]methionine_JJ ,_, and_CC equal_JJ amounts_NNS of_IN DNA_NN constructs_NNS expressing_VBG Myc-SmB_NP (_( lanes_NNS 4_CD --_: 6_CD )_) ,_, Myc-SMN_JJ (_( lanes_NNS 7_CD --_: 9_CD )_) ,_, Myc-SMNDeltaN27_JJ (_( lanes_NNS 10_CD --_: 12_LS )_) ,_, or_CC no_DT additional_JJ DNA_NN (_( lanes_NNS 1_CD --_: 3_LS )_) ._SENT At_IN 30_CD ,_, 60_CD ,_, and_CC 90_CD min_NN after_IN the_DT start_NN of_IN the_DT RRL_NP reactions_NNS ,_, telomerase_NN activity_NN was_VBD assayed_VBN by_IN the_DT TRAP_NP assay_NN ._SENT Each_DT TRAP_NP reaction_NN included_VBD an_DT internal_JJ control_NN (_( IC_NP )_) to_TO normalize_VB for_IN variation_NN in_IN PCR_NP efficiency_NN ._SENT (_( B_NP )_) At_IN 90_CD min_NN after_IN the_DT start_NN of_IN the_DT RRL_NP reactions_NNS ,_, equal_JJ amounts_NNS were_VBD analyzed_VBN by_IN SDS-PAGE_NP and_CC autoradiography_NN ._SENT (_( C_LS )_) The_DT telomerase_NN activity_NN was_VBD calculated_VBN as_IN the_DT ratio_NN between_IN the_DT intensity_NN of_IN the_DT telomerase_JJ ladder_NN products_NNS and_CC the_DT intensity_NN of_IN the_DT internal_JJ PCR_NP control_NN ._SENT A_DT ratio_NN of_IN this_DT telomerase_NN activity_NN value_NN to_TO the_DT amount_NN of_IN in_IN vitro_NN --_: translated_VBN hTERT_NN measured_VBN by_IN the_DT intensity_NN of_IN the_DT S35-labeled_JJ hTERT_NN was_VBD calculated_VBN to_TO generate_VB the_DT relative_JJ telomerase_NN activity_NN ._SENT The_DT activities_NNS from_IN three_CD independent_JJ experiments_NNS performed_VBN in_IN the_DT presence_NN of_IN SmB_NP (_( diamonds_NNS )_) ,_, wild-ty_NN 